Evaluation of the high-pressure extrusion technique as a method for sizing plasmid DNA-containing cationic liposomes

References

• Ahsan, F., Rivas, I. P., Khan, M. A., Torres Suarez, A. I. (2002). Targeting to macrophages: role of physicochemical properties of particulate carriers—liposomes and microspheresmp_semion the phagocytosis by macrophages. J Contr Rel 79:29–40.
   PubMed Web of Science ®Google Scholar
• Bacon, A., Caparros-Wanderley, W., Zadi, B., Gregoriadis, G. (2002). Induction of a cytotoxic T lymphocyte (CTL) response to plasmid DNA delivered via Lipodine liposomes. J Liposome Res 12:173–183.
   PubMed Web of Science ®Google Scholar
• Baldwin, S. L., D’Souza, C. D., Orme, I. M., Liu, M. A., Huygen, K., Denis, O., et al. (1999). Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A. Tuber Lung Dis 79:251–259.
   PubMedGoogle Scholar
• Bally, M. B., Zhang, Y.-P., Wong, F. M. P., Kong, S., Wasan, E., Reimer, D. L. (1997). Lipid/DNA complexes as an intermediate in the preparation of particles for gene transfer: an alternative to cationic liposome/DNA aggregates. Adv Drug Deliv Rev 24:275–290.
   Web of Science ®Google Scholar
• Bauer, S., Kirschning, C. J., Hacker, H., Redecke, V., Hausmann, S., Akira, S., et al. (2001). Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci U S A 98:9237–9242.
   PubMed Web of Science ®Google Scholar
• Bligh, E. G., Dyer, W. J. (1959). A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911–917.
   PubMedGoogle Scholar
• Brewer, J. M., Pollock, K. G., Tetley, L., Russell, D. G. (2004). Vesicle size influences the trafficking, processing, and presentation of antigens in lipid vesicles. J Immunol 173:6143–6150.
   PubMed Web of Science ®Google Scholar
• Christensen, D., Korsholm, K. S., Rosenkrands, I., Lindenstrom, T., Andersen, P., Agger, E. M. (2007). Cationic liposomes as vaccine adjuvants. Exp Rev Vaccines 6:785–796.
   PubMed Web of Science ®Google Scholar
• Conner, S. D., Schmid, S. L. (2003). Regulated portals of entry into the cell. Nature 422:37–44.
   PubMed Web of Science ®Google Scholar
• Foged, C., Brodin, B., Frokjaer, S., Sundblad, A. (2005). Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm 298:315–322.
   PubMed Web of Science ®Google Scholar
• Greenland, J. R., Letvin, N. L. (2007). Chemical adjuvants for plasmid DNA vaccines. Vaccine 25:3731–3741.
   PubMed Web of Science ®Google Scholar
• Gregoriadis, G., Bacon, A., Caparros-Wanderley, W., McCormack, B. (2002). A role for liposomes in genetic vaccination. Vaccine 20(Suppl 5):B1–B9.
   Google Scholar
• Gregoriadis, G., Bacon, A., Caparros-Wanderley, W., McCormack, B. (2003). Plasmid DNA vaccines: entrapment into liposomes by dehydration-rehydration. Meth Enzymol 367:70–80.
   PubMed Web of Science ®Google Scholar
• Gregoriadis, G., Saffie, R., De Souza, J. B. (1997). Liposome-mediated DNA vaccination. FEBS Lett 402:107–110.
   PubMed Web of Science ®Google Scholar
• Gregoriadis, G., Saffie, R., Hart, S. L. (1996). High yield incorporation of plasmid DNA within liposomes: effect on DNA integrity and transfection efficiency. J Drug Targ 3:469–475.
   PubMed Web of Science ®Google Scholar
• Huygen, K., Content, J., Denis, O., Montgomery, D. L., Yawman, A. M., Deck, R. R., et al. (1996). Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med 2:893–898.
   PubMed Web of Science ®Google Scholar
• Jechlinger, W. (2006). Optimization and delivery of plasmid DNA for vaccination. Exp Rev Vaccines 5:803–825.
   PubMed Web of Science ®Google Scholar
• Jilek, S., Merkle, H. P., Walter, E. (2005). DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells. Adv Drug Deliv Rev 57:377–390.
   PubMed Web of Science ®Google Scholar
• Krieg, A. M. (2002). CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20:709–760.
   PubMed Web of Science ®Google Scholar
• Kutzler, M. A., Weiner, D. B. (2008). DNA vaccines: ready for prime time? Nat Rev Genet 9:776–788.
   PubMed Web of Science ®Google Scholar
• Laddy, D. J., Weiner, D. B. (2006). From plasmids to protection: a review of DNA vaccines against infectious diseases. Int Rev Immunol 25:99–123.
   PubMed Web of Science ®Google Scholar
• Liu, M. A., Ulmer, J. B. (2005). Human clinical trials of plasmid DNA vaccines. Adv Genet 55:25–40.
   PubMed Web of Science ®Google Scholar
• Lonez, C., Vandenbranden, M., Ruysschaert, J. M. (2008). Cationic liposomal lipids: from gene carriers to cell signaling. Prog Lipid Res 47:340–347.
   PubMed Web of Science ®Google Scholar
• Ma, B., Zhang, S., Jiang, H., Zhao, B., Lv, H. (2007). Lipoplex morphologies and their influences on transfection efficiency in gene delivery. J Contr Rel 123:184–194.
   PubMed Web of Science ®Google Scholar
• McNeil, S. E., Vangala, A., Bramwell, V. W., Hanson, P. J., Perrie, Y. (2010). Lipoplexes formulation and optimisation: in vitro transfection studies reveal no correlation with in vivo vaccination studies. Curr Drug Deliv 7:175–187.
   PubMedGoogle Scholar
• O’Hagan, D. T., Singh, M., Ulmer, J. B. (2004). Microparticles for the delivery of DNA vaccines. Immunol Rev 199:191–200.
   PubMed Web of Science ®Google Scholar
• Ottenhoff, T. H. (2009). Overcoming the global crisis: “yes, we can”, but also for TB...? Eur J Immunol 39:2014–2020.
   PubMed Web of Science ®Google Scholar
• Perrie, Y., Frederik, P. M., Gregoriadis, G. (2001). Liposome-mediated DNA vaccination: the effect of vesicle composition. Vaccine 19:3301–3310.
   PubMed Web of Science ®Google Scholar
• Perrie, Y., Gregoriadis, G. (2000). Liposome-entrapped plasmid DNA: characterisation studies. Biochim Biophys Acta 1475:125–132.
   PubMed Web of Science ®Google Scholar
• Perrie, Y., Mohammed, A. R., Kirby, D. J., McNeil, S. E., Bramwell, V. W. (2008). Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens. Int J Pharm 364:272–280.
   PubMed Web of Science ®Google Scholar
• Pitard, B., Aguerre, O., Airiau, M., LaChages, A. M., Boukhnikachvili, T., Byk, G., et al. (1997). Virus-sized self-assembling lamellar complexes between plasmid DNA and cationic micelles promote gene transfer. Proc Natl Acad Sci U S A 94:14412–14417.
   PubMed Web of Science ®Google Scholar
• Rejman, J., Oberle, V., Zuhorn, I. S., Hoekstra, D. (2004). Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 377:159–169.
   PubMed Web of Science ®Google Scholar
• Rice, J., Ottensmeier, C. H., Stevenson, F. K. (2008). DNA vaccines: precision tools for activating effective immunity against cancer. Nat Rev Cancer 8:108–120.
   PubMed Web of Science ®Google Scholar
• Rouser, G., Fkeischer, S., Yamamoto, A. (1970). Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5:494–496.
   PubMed Web of Science ®Google Scholar
• Scheerlinck, J. P., Greenwood, D. L. (2008). Virus-sized vaccine delivery systems. Drug Discov Today 13:882–887.
   PubMed Web of Science ®Google Scholar
• Simoes, S., Filipe, A., Faneca, H., Mano, M., Penacho, N., Duzgunes, N., et al. (2005). Cationic liposomes for gene delivery. Exp Opin Drug Deliv 2:237–254.
   PubMedGoogle Scholar
• Singh, M., Briones, M., Ott, G., O’Hagan, D. (2000). Cationic microparticles: a potent delivery system for DNA vaccines. Proc Natl Acad Sci U S A 97:811–816.
   PubMed Web of Science ®Google Scholar
• Singh, M., Chakrapani, A., O’Hagan, D. (2007). Nanoparticles and microparticles as vaccine-delivery systems. Exp Rev Vaccines 6:797–808.
   PubMed Web of Science ®Google Scholar
• Templeton, N. S., Lasic, D. D., Frederik, P. M., Strey, H. H., Roberts, D. D., Pavlakis, G. N. (1997). Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol 15:647–652.
   PubMed Web of Science ®Google Scholar
• Ulmer, J. B., Wahren, B., Liu, M. A. (2006). Gene-based vaccines: recent technical and clinical advances. Trends Mol Med 12:216–222.
   PubMed Web of Science ®Google Scholar
• van der Kleij, D., Latz, E., Brouwers, J. F., Kruize, Y. C., Schmitz, M., Kurt-Jones, E. A., et al. (2002). A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J Biol Chem 277:48122–48129.
   PubMed Web of Science ®Google Scholar
• van Duin, D., Medzhitov, R., Shaw, A. C. (2006). Triggering TLR signaling in vaccination. Trends Immunol 27:49–55.
   PubMed Web of Science ®Google Scholar
• Vangasseri, D. P., Cui, Z., Chen, W., Hokey, D. A., Falo, L. D., Jr., Huang, L. (2006). Immunostimulation of dendritic cells by cationic liposomes. Mol Membr Biol 23:385–395.
   PubMed Web of Science ®Google Scholar
• Xiang, S. D., Scholzen, A., Minigo, G., David, C., Apostolopoulos, V., Mottram, P. L., et al. (2006). Pathogen recognition and development of particulate vaccines: does size matter? Methods 40:1–9.
   PubMed Web of Science ®Google Scholar
• Yan, W., Chen, W., Huang, L. (2007). Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK, and induction of chemokines. Mol Immunol 44:3672–3681.
   PubMed Web of Science ®Google Scholar
• Zuhorn, I. S., Engberts, J. B., Hoekstra, D. (2007). Gene delivery by cationic lipid vectors: overcoming cellular barriers. Eur Biophys J 36:349–362.
   PubMed Web of Science ®Google Scholar